<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01765972</url>
  </required_header>
  <id_info>
    <org_study_id>CR-5252</org_study_id>
    <nct_id>NCT01765972</nct_id>
  </id_info>
  <brief_title>Open Eye Corneal Swelling With Daily Disposable Contact Lenses and no Lens Wear</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this clinical trial is to evaluate the eye's response to three test
      soft contact lenses as well as no lens wear, with respect to Corneal Staining.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Change From Baseline of Corneal Swelling 8 Hours Post Fit</measure>
    <time_frame>8 hours post fit</time_frame>
    <description>Central corneal thickness was measured at baseline and 8-hour post fit with a modified optical pachometer on a Zeiss biomicroscope, interfaced to a PC. The pachometry measurement included seven readings; the computer is programmed to remove the high and low readings and to calculate the average of the remaining five readings. Only a single central corneal thickness measurement, the average of the 5 readings, was recorded by the investigator in the eCRF. The average percent change from baseline of corneal swelling was reported and was calculated as: ((Post fit - Baseline)/ Baseline) X 100.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Corneal Swelling</condition>
  <arm_group>
    <arm_group_label>Test 1/Spectacles/Test 2/Test 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects assigned randomly to this arm will wear the study lenses sequentially as TEST 1 (etafilcon A with Lacreon), spectacles, TEST 2 (etafilcon A with Lacreon with print) and TEST 3 (etafilcon A with print) in both eyes for 8 +/-1 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 2/Test 3/ Spectacles/Test 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects assigned randomly to this arm will wear the study lenses sequentially as TEST 2 (etafilcon A with Lacreon with print), TEST 3 (etafilcon A with print), spectacles and TEST 1 (etafilcon A with Lacreon) in both eyes for 8 +/-1 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test 3/Test 1/ Test 2/ Spectacles</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects assigned randomly to this arm will wear the study lenses sequentially as TEST 3 (etafilcon A with print), TEST 1 (etafilcon A with Lacreon), TEST 2 (etafilcon A with Lacreon with print) and spectacles in both eyes for 8 +/-1 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spectacles/Test 2/Test 1/Test 3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects assigned randomly to this arm will wear the study lenses sequentially as spectacles, TEST 2 (etafilcon A with Lacreon with print), TEST 1 (etafilcon A with Lacreon) and TEST 3 (etafilcon A with print) in both eyes for 8 +/-1 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A with Lacreon</intervention_name>
    <description>contact lens with Lacreon</description>
    <arm_group_label>Test 1/Spectacles/Test 2/Test 3</arm_group_label>
    <arm_group_label>Test 2/Test 3/ Spectacles/Test 1</arm_group_label>
    <arm_group_label>Test 3/Test 1/ Test 2/ Spectacles</arm_group_label>
    <arm_group_label>Spectacles/Test 2/Test 1/Test 3</arm_group_label>
    <other_name>Test 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A with Lacreon with print</intervention_name>
    <description>contact lens with Lacreon and cosmetic print</description>
    <arm_group_label>Test 1/Spectacles/Test 2/Test 3</arm_group_label>
    <arm_group_label>Test 2/Test 3/ Spectacles/Test 1</arm_group_label>
    <arm_group_label>Test 3/Test 1/ Test 2/ Spectacles</arm_group_label>
    <arm_group_label>Spectacles/Test 2/Test 1/Test 3</arm_group_label>
    <other_name>Test 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>etafilcon A with print</intervention_name>
    <description>contact lens with print</description>
    <arm_group_label>Test 1/Spectacles/Test 2/Test 3</arm_group_label>
    <arm_group_label>Test 2/Test 3/ Spectacles/Test 1</arm_group_label>
    <arm_group_label>Test 3/Test 1/ Test 2/ Spectacles</arm_group_label>
    <arm_group_label>Spectacles/Test 2/Test 1/Test 3</arm_group_label>
    <other_name>Test 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectacles (habitual)</intervention_name>
    <description>Spectacles</description>
    <arm_group_label>Test 1/Spectacles/Test 2/Test 3</arm_group_label>
    <arm_group_label>Test 2/Test 3/ Spectacles/Test 1</arm_group_label>
    <arm_group_label>Test 3/Test 1/ Test 2/ Spectacles</arm_group_label>
    <arm_group_label>Spectacles/Test 2/Test 1/Test 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and
             receive a fully executed copy of the form.

          2. The subject must appear able and willing to adhere to the instructions set forth in
             the clinical protocol.

          3. The subject must be between 18 and 45 years of age.

          4. The subject must be an adapted soft contact lens wearer in both eyes.

          5. The subject must be of East or Southeast Asian descent, e.g. ethnic Chinese, Japanese,
             Korean, Malay, Vietnamese, Indonesian, Filipino, etc. (it is preferred but not
             required that both the subject's biological parents are East or Southeast Asian
             ethnicity, by self report).

          6. The subject's vertex corrected spherical equivalent distance refraction must be in the
             range of -1.00 to -6.00 D in each eye.

          7. The subject's refractive cylinder must be no more than 1.00D in each eye.

          8. The subject must have best corrected visual acuity of +0.14 logMAR (equivalent to
             20/25-2) or better in each eye.

          9. Subjects must own a wearable pair of spectacles and wear them on the day of the
             initial visit, during the washout before each phase and during the no lens wear phase.

         10. The subject must have normal eyes (i.e., no ocular medications or infections of any
             type).

        Exclusion Criteria:

          1. Are currently pregnant or lactating by self report (subjects who become pregnant
             during the study will be discontinued).

          2. Have any ocular or systemic allergies or diseases that may interfere with contact lens
             wear.

          3. Have any systemic disease, autoimmune disease, or use of medication, which may
             interfere with contact lens wear. This may include, but may not be limited to,
             diabetes. hyperthyroidism, recurrent herpes simplex/zoster, Sjogren's syndromes,
             xerophthalmia, acne rosacea, Stevens-Johnson syndromes, HIV/AIDS, hepatitis, and
             tuberculosis.

          4. Use of any topical medications such aas eye drops or ointments.

          5. Have entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of
             recurrent corneal erosion, or aphakia.

          6. Had any previous, or planned ocular or intraocular surgery (e.g. cataract surgery,
             radial keratotomy, PRK, LASIK, etc.).

          7. Have any grade 2.0 or greater slit lamp findings (e.g. edema, corneal
             neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on
             the Efron classification scale or any other ocular abnormality that may contraindicate
             contact lens wear.

          8. Have any known hypersensitivity or allergic reaction to one of the study products.

          9. Have any ocular infection.

         10. Have any corneal distortion resulting from previous hard or rigid gas permeable
             contact lens wear.

         11. Have participated in any contact lens or lens care product clinical trial within 14
             days prior to study enrollment.

         12. Have any infectious disease (e.g. hepatitis, tuberculosis) or a contagious
             immunosuppressive disease (e.g. HIV by self report).

         13. Currently wear their contact lenses on an extended wear basis.

         14. Are an employee of the investigational clinic (e.g. Investigator, Coordinator,
             Technician)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2013</study_first_submitted>
  <study_first_submitted_qc>January 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2013</study_first_posted>
  <results_first_submitted>June 10, 2016</results_first_submitted>
  <results_first_submitted_qc>June 10, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 20, 2016</results_first_posted>
  <last_update_submitted>July 19, 2016</last_update_submitted>
  <last_update_submitted_qc>July 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 39 subjects were enrolled in this study. Of those enrolled subjects 15 subjects did not meet the eligibility criteria. The remaining 24 subjects were successfully dispensed a study lens and completed the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Test 1/Spectacle/Test 2/ Test 3</title>
          <description>Subjects received Test 1 (etafilcon A with Laceron) and then received spectacle and then received Test 2 (etafilcon A with print) and then received Test 3 (etafilcon A with print).</description>
        </group>
        <group group_id="P2">
          <title>Test 2/ Test 3/ Spectacle/ Test 1</title>
          <description>Subjects received Test 2 (etafilcon A with print) and then received Test 3 (etafilcon A with print) and then received spectacle and then received Test 1 (etafilcon A with Laceron).</description>
        </group>
        <group group_id="P3">
          <title>Test 3/ Test 1/ Test 2/ Spectacle</title>
          <description>Subjects received Test 3 (etafilcon A with print) and then received Test 1 (etafilcon A with Laceron) and then received Test 2 (etafilcon A with print) and then received spectacle.</description>
        </group>
        <group group_id="P4">
          <title>Spectacle/ Test 2/ Test 1/ Test 3</title>
          <description>Subjects received spectacle and then received Test 2 (etafilcon A with print) and then received Test 1 (etafilcon A with Laceron) and then received Test 3 (etafilcon A with print) .</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="6"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects that were dispensed a study lens.</population>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>All subjects that were dispensed a study lens.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.13" spread="2.437"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Change From Baseline of Corneal Swelling 8 Hours Post Fit</title>
        <description>Central corneal thickness was measured at baseline and 8-hour post fit with a modified optical pachometer on a Zeiss biomicroscope, interfaced to a PC. The pachometry measurement included seven readings; the computer is programmed to remove the high and low readings and to calculate the average of the remaining five readings. Only a single central corneal thickness measurement, the average of the 5 readings, was recorded by the investigator in the eCRF. The average percent change from baseline of corneal swelling was reported and was calculated as: ((Post fit - Baseline)/ Baseline) X 100.</description>
        <time_frame>8 hours post fit</time_frame>
        <population>Analysis population consists of subjects that completed all study visits without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test 1 (Etafilcon A With Lacreon)</title>
            <description>Subjects that received Test 1 (etafilcon A with Lacreon) lens in any of the 4 periods of this study.</description>
          </group>
          <group group_id="O2">
            <title>Test 2 (Etafilcon A With Lacreon With Print)</title>
            <description>Subjects that received Test 2 (etafilcon A with Lacreon with print) lens in any of the 4 periods of this study.</description>
          </group>
          <group group_id="O3">
            <title>Test 3 (Etafilcon A With Print)</title>
            <description>Subjects that received Test 3 (etafilcon A with print) lens in any of the 4 periods of this study.</description>
          </group>
          <group group_id="O4">
            <title>Spectacle</title>
            <description>Subjects that wore spectacles in any of the 4 periods of this study.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Change From Baseline of Corneal Swelling 8 Hours Post Fit</title>
          <description>Central corneal thickness was measured at baseline and 8-hour post fit with a modified optical pachometer on a Zeiss biomicroscope, interfaced to a PC. The pachometry measurement included seven readings; the computer is programmed to remove the high and low readings and to calculate the average of the remaining five readings. Only a single central corneal thickness measurement, the average of the 5 readings, was recorded by the investigator in the eCRF. The average percent change from baseline of corneal swelling was reported and was calculated as: ((Post fit - Baseline)/ Baseline) X 100.</description>
          <population>Analysis population consists of subjects that completed all study visits without a major protocol deviation.</population>
          <units>percentage of change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="24"/>
                <count group_id="O4" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.07" spread="0.288"/>
                    <measurement group_id="O2" value="-0.02" spread="0.286"/>
                    <measurement group_id="O3" value="0.14" spread="0.350"/>
                    <measurement group_id="O4" value="-0.06" spread="0.293"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Entire duration of study (approximately 4 Months)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Spectacle</title>
          <description>Subjects wore spectacles in any of the 4 periods of this study.</description>
        </group>
        <group group_id="E2">
          <title>Test 1 (Etafilcon A With Lacreon)</title>
          <description>Subjects received Test 1 (etafilcon A with Lacreon) in any of the 4 periods of this study.</description>
        </group>
        <group group_id="E3">
          <title>Test 2 (Etafilcon A With Lacreon With Print)</title>
          <description>Subjects received Test 2 (etafilcon A with Lacreon with print) in any of the 4 periods of this study.</description>
        </group>
        <group group_id="E4">
          <title>Test 3 (Etafilcon A With Print)</title>
          <description>Subjects received Test 3 (etafilcon A with print) in any of the 4 periods of this study.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="24"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Katherine Osborn Lorenz, OD, MS</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care Inc.</organization>
      <phone>614 459-9477</phone>
      <email>KOSBORN@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

